Shares of HIMS experienced a dramatic slump today following the unexpected cancellation of its agreement with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending the company's stock price plummeting by more than 20%. The reason for the dissolution of the partnership